RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
Clinical trial NCT00458367 · COMPLETED
Trial details
- NCT number
- NCT00458367
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2002-06-01
- Enrollment
- 5296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.